NAD therapy ranges from $30/month in pill form to over $1,000 per IV session. The marketing implies all three methods are doing roughly the same thing at different price points. They’re not. Most NAD pills aren’t actually NAD. They’re precursors your body converts into NAD.
Injections and IVs are usually NAD itself. Those two things behave very differently inside the body, which changes which method makes sense for what you’re trying to achieve.
This article breaks down how each delivery method actually works, what the evidence does and doesn’t support, the true cost over 12 months, and how to match the method to your goal.
NAD vs NAD Precursors: Why Most Pills Aren’t Actually NAD
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme, a helper molecule, that every cell in your body uses to produce energy, repair DNA, and regulate metabolism. Your body makes its own NAD from a handful of building blocks (called precursors). The most common precursors are:
- Nicotinamide riboside (NR), a form of vitamin B3, sold under brand names like Niagen
- Nicotinamide mononucleotide (NMN), one step closer to NAD in the conversion pathway
- Niacin and niacinamide, older forms of vitamin B3
When you take an oral NAD supplement, what you’re almost always taking is one of these precursors, not NAD itself. Your gut absorbs the precursor, your liver and cells convert it into NAD over time, and your blood NAD levels rise gradually.
Injections and IVs are different. They typically deliver NAD itself directly into your bloodstream or tissue, bypassing the conversion process.
| Compound | What It Is | How Your Body Uses It |
| NR (oral) | NAD precursor (vitamin B3 form) | Converted to NAD over hours via liver and cells |
| NMN (oral) | NAD precursor (one step from NAD) | Converted to NR first, then to NAD |
| NAD+ (injection or IV) | NAD itself | Delivered directly into blood; cells take up portions or break it down into precursors |
| Niacinamide (oral) | Basic B3 form | Lower-efficiency conversion pathway |
Your cells don’t passively absorb intact NAD from the bloodstream. NAD is a relatively large molecule and doesn’t cross cell membranes easily. Most of it gets broken down extracellularly into smaller precursors, which then enter cells and get rebuilt into NAD inside them (Bonkowski & Sinclair, 2016).
In other words, even when you “deliver NAD directly” via IV, much of what your cells actually use is the precursor pool that NAD gets broken down into. Which means the “100% bioavailability” claim about IV NAD is true for blood levels, but misleading about what your cells receive.
This matters because it changes how you should think about the three methods. The choice isn’t really “more bioavailable vs less bioavailable.” It’s about how fast you raise NAD-related substrates, how long they stay elevated, how much time and money the method requires, and whether your goal calls for acute spikes or steady support.
NAD Pills vs Injections vs IV: Quick Comparison
Here’s the high-level view before going deeper into each method.
| Factor | Pills (NR/NMN) | Injections (SC/IM) | IV Infusion |
| What’s delivered | NAD precursor | NAD itself | NAD itself |
| Bioavailability | Lower (~10-30%) | High (estimated 70-90%) | Highest blood levels (100%) |
| Time per dose | Seconds | 1-2 minutes | 2-4 hours |
| Frequency | Daily | 1-3x weekly | Weekly to monthly |
| Monthly cost | $30-150 | $150-400 | $800-3,000+ |
| Side effects | Mild (occasional flushing, GI) | Mild local (site irritation) | Common (flushing, chest tightness, nausea) |
| Evidence quality | Strongest (most RCTs) | Limited | Very limited |
| Best for | Long-term maintenance, baseline support | Routine protocols, IV alternative | Acute loading, specific clinical use |
The most important thing this table reveals is evidence quality runs in the opposite direction of price. The cheapest option has the most peer-reviewed human data behind it. The most expensive option has the least. That doesn’t make IV worthless, but it should reframe the assumption that more expensive equals better.
NAD Pills: How They Work, What They Cost, and What to Expect
Oral NAD precursors are the most studied delivery format in humans. NR (nicotinamide riboside) has more than 50 published human clinical trials behind it. NMN has fewer but a growing base. Both have been shown to reliably raise blood NAD levels.
What the Bioavailability Data Actually Shows
In the first pharmacokinetic study of NR in humans, a single oral dose produced dose-dependent increases in blood NAD, with peak blood NAD rising up to 2.7-fold at higher doses (Trammell et al., Nature Communications 2016). In a longer-term randomized trial, 1,000 mg/day of NR for 6 weeks increased blood NAD by roughly 60% in middle-aged and older adults (Martens et al., Nature Communications 2018).
For NMN, a placebo-controlled trial in older men using 250 mg/day for 12 weeks showed significant increases in blood NAD and improvements in some muscle function measures (Igarashi et al., NPJ Aging 2022).
So pills do raise NAD. That part is established.
The Limitation of NAD Pills
Raising blood NAD and producing meaningful clinical benefits are two different outcomes. A recent comprehensive review in Nature Metabolism concluded that while preclinical studies in animals support NAD precursors as promising for healthy aging, human clinical trials have shown limited efficacy on outcomes like muscle function, cognition, and aging markers (Pirinen et al., Nature Metabolism 2025).
In plain terms: pills reliably raise the number on the lab report. Whether that translates into feeling better, performing better, or aging slower is much less certain.
The NMN Regulatory Situation
If you’re shopping for NMN specifically, the regulatory history matters:
- 2022: FDA pulled NMN’s status as a dietary supplement after it entered drug-development pipelines
- 2022-2025: NMN was technically not lawful as a supplement, but enforcement was inconsistent
- September 2025: FDA reversed course and reinstated NMN as a lawful dietary supplement following a lawsuit by industry groups
NMN supplements are now legal again, but the years of regulatory gray zone created a market full of unregulated, untested products. Quality varies widely. NR, by contrast, has had stable regulatory status the entire time and stronger third-party quality verification.
When Pills Are the Right Call
- You want baseline NAD support without disrupting your schedule
- You’re cost-conscious
- You’re comfortable with gradual effects rather than acute spikes
- You’re treating this as long-term maintenance, not a fix for a specific symptom
When Pills Are the Wrong Call
- You’re expecting dramatic short-term effects
- You have severe absorption issues (gut disorders, post-bariatric surgery)
- You’ve tried oral precursors for 3+ months and seen no measurable benefit
NAD Injections: How They Compare to IV Drips and Oral Supplements
NAD injections sit in the middle ground. They deliver NAD itself (not a precursor), bypass the digestive system entirely, and don’t require sitting in a clinic for hours. They’ve become increasingly popular among people who want IV-style delivery without the IV-style time and cost.
There are two main injection routes:
- Subcutaneous (SC): Under the skin, usually in the abdomen or thigh. Slower absorption, longer-lasting effect.
- Intramuscular (IM): Into muscle tissue, usually the deltoid or glute. Faster absorption, shorter duration.
The Pharmacokinetics in Plain Terms
Subcutaneous NAD typically peaks in the bloodstream 1-2 hours after injection and maintains elevated levels for 8-12 hours. Intramuscular injection peaks faster, often within 30-60 minutes, with a shorter duration of action. Both bypass the first-pass metabolism that limits oral absorption.
Typical dosing ranges:
- Subcutaneous: Starting around 20 mg, titrating up to ~100 mg per injection, 1-3 times weekly
- Intramuscular: 25-100 mg per injection, 1-2 times weekly
The Tolerability Advantage
Compared to IV NAD, injections produce far fewer of the systemic side effects (flushing, chest pressure, nausea) that come from pushing NAD into the bloodstream quickly. A recent retrospective study found that NR delivered intravenously caused noticeably fewer adverse experiences than IV NAD, and that the slower delivery profiles in general appear better tolerated (Frontiers in Aging 2026).
The slower release from a subcutaneous depot offers a similar tolerability advantage at much lower cost than IV.
Note: Almost all NAD used for injection comes from compounding pharmacies, not standardized pharmaceutical manufacturers. Quality varies, and the FDA has flagged compounded products across multiple categories for dosing inconsistencies. If you’re going the injection route, the pharmacy matters as much as the protocol.
When Injections Are the Right Call
- You want direct NAD delivery without the time cost of IV
- You’re already comfortable with self-injection (TRT patients, peptide users)
- You’re building a long-term protocol rather than a one-time loading phase
- You want IV-like effects without IV-like side effects
When Injections Are the Wrong Call
- You’re not willing to self-inject and don’t have clinical access
- You want the maximum possible blood NAD spike (IV is better for that)
- You’re on a tight budget where oral makes more sense
NAD IV Therapy: Is It Worth the Cost?
A typical NAD IV delivers 500-1,000 mg of NAD over 2-4 hours, sometimes longer. Pushing NAD into the bloodstream too quickly produces uncomfortable side effects: flushing, chest tightness, abdominal pressure, nausea, and a racing heartbeat. Most clinics titrate the infusion rate based on patient tolerance, which is part of why sessions can stretch to 4+ hours.
Costs typically range from $400 to over $1,000 per session, with most clinics recommending an initial “loading phase” of 4-10 sessions followed by maintenance.
What the Evidence Actually Shows
There are very few peer-reviewed randomized controlled trials of IV NAD in healthy adults. Most of the clinical evidence comes from two specific contexts:
- Substance use disorder and addiction recovery, where IV NAD has been used clinically for decades, with case-series-level evidence of benefit (Blum et al., 2024)
- Pilot pharmacokinetic studies, confirming that IV NAD does in fact raise blood NAD and produces measurable changes in metabolic markers (Grant et al., 2019)
There’s also a single small study showing IV NAD improved cognitive test performance in healthy volunteers compared to saline (Krumins et al., 2021). It’s interesting but not conclusive, small sample, single trial, not yet replicated.
What’s largely missing: large-scale RCTs in healthy adults showing meaningful, lasting benefits to energy, cognition, performance, or aging markers from IV NAD specifically.
The Subjective Experience Trap
Many patients report feeling better after IV NAD sessions. That’s real, but it’s worth being honest about what’s contributing:
- The saline volume itself (mild rehydration boost)
- The placebo effect of a multi-hour clinical experience
- The relief of finishing a 3-hour session
- Genuine NAD-mediated effects (likely some, magnitude unclear)
Separating those is hard. But it’s why the “I felt amazing after my drip” testimonials shouldn’t be confused with clinical evidence.
When IV Is the Right Call
- Specific clinical indications (recovery contexts, severe NAD depletion states)
- A short-term loading protocol to rapidly elevate NAD before transitioning to injections or oral
- Patients where injections aren’t feasible
- Cost isn’t a meaningful constraint
When IV Is the Wrong Call
- Routine wellness or general “anti-aging” support
- Tight budgets
- Anyone expecting durable results from one or two sessions
- Anyone who hasn’t tried lower-cost options first
Which NAD Therapy Is Right for You? (By Goal and Budget)
Here’s the decision framework based on what you’re actually trying to achieve.
| Your Goal | Best Starting Option | Why |
| General longevity support, budget-conscious | Oral NR (300-1,000 mg/day) | Best cost-to-evidence ratio, most studied |
| Maintenance protocol with steady delivery | Subcutaneous injections | Bypasses gut, manageable cost, fewer side effects than IV |
| Acute loading before a long event or recovery | IV NAD (4-10 session series) | Fastest way to raise blood levels significantly |
| Already on TRT, peptides, or injection-based protocols | SC injections | Easy to integrate, similar delivery technique |
| Recovery from substance use, severe fatigue states | IV (clinical setting) | Where most clinical evidence exists |
| General wellness curiosity, no specific issue | Oral NR or skip entirely | Evidence doesn’t justify $500+/session for non-specific goals |
| You’ve tried oral and felt nothing | SC injections trial | Higher delivery without IV cost |
| Cost is no object, you want maximum effect | IV loading → SC maintenance | Combines acute and sustained delivery |
The key insight buried in this table: starting at the cheapest option that fits your goal isn’t being stingy. It’s matching the evidence. If oral precursors don’t move the needle for you over 2-3 months, that’s useful information that justifies stepping up. Starting with IV first means you’ve spent thousands of dollars before knowing whether you needed to.
NAD Therapy Cost: Pills vs Injections vs IV Over 12 Months
The monthly cost gets quoted often. The annual cost rarely does. Here’s the realistic math.
| Method | Typical Dose/Frequency | Monthly Cost | 12-Month Cost |
| Oral NR (Niagen, 300mg) | Daily | $30-60 | $360-720 |
| Oral NMN (500mg) | Daily | $50-150 | $600-1,800 |
| SC injections (100mg, 2x/week) | Weekly self-injection | $150-300 | $1,800-3,600 |
| IM injections (clinic-administered) | Weekly visit | $200-400 | $2,400-4,800 |
| IV NAD (loading phase) | 4-10 sessions, 1-3 months | $1,600-10,000 (one-time) | — |
| IV NAD (maintenance) | 1-2x/month after loading | $400-2,000 | $4,800-24,000+ |
A few takeaways:
- The IV-only patient spending $800/session twice monthly is on track for $19,200/year. Most of them don’t realize this until year two.
- The oral-only patient at $50/month spends $600/year, similar to what one IV session costs at a high-end clinic.
- The hybrid approach (IV loading, then injections or oral for maintenance) is often the most cost-efficient for people who want significant intervention without ongoing IV costs.
The right question isn’t “what does this cost per session?” It’s “what’s the total cost over a year, and what evidence supports that level of spending for my specific goal?”
What NAD Clinics Won’t Tell You Before You Pay
A few realities that rarely make it into the standard NAD therapy pitch.
- The 100% bioavailability claim is misleading. IV NAD does deliver NAD into your bloodstream at full concentration. But your cells can’t directly absorb intact NAD molecules from the blood. Most NAD gets broken down extracellularly into smaller precursors that cells then use to rebuild NAD intracellularly. The number on the bioavailability chart describes blood levels, not what your cells actually receive.
- Compounded NAD quality varies wildly. Injectable and IV NAD is almost always sourced from compounding pharmacies. Unlike standardized pharmaceutical manufacturing, compounded products can have significant variation in concentration, purity, and stability. If you’re paying $400+ per session, the pharmacy behind the bag matters as much as the protocol.
- Most clinical evidence for IV NAD comes from contexts that don’t transfer. The strongest IV NAD data is in substance use recovery and severe neurodegenerative disease. These are populations with profoundly disrupted NAD metabolism. The extrapolation from “it helps people in addiction recovery” to “it will optimize a healthy 45-year-old’s energy levels” is much larger than the marketing implies.
- Some of what you feel after an IV is the experience, not the NAD. A 3-hour clinical session involves rest, hydration, a calm environment, and the psychological weight of investing in your health. These produce real subjective effects independent of the NAD itself. That doesn’t mean the NAD isn’t doing anything. It means separating “what the molecule did” from “what the experience did” is much harder than testimonials suggest.
- For men on TRT or hormone optimization protocols, NAD is a supporting player, not a replacement. NAD interacts with mitochondrial function, recovery, and metabolism. It can complement well-managed hormone therapy. But if your fatigue, brain fog, or low energy is driven by low testosterone, thyroid dysfunction, or poor sleep, no amount of NAD will fix that. Treating NAD as a substitute for a proper hormonal workup is one of the more expensive mistakes in this space.
Next Steps
Match the method to the goal, not the marketing. Most people optimizing healthspan don’t need IV. Most people who think they need IV haven’t tried oral or injections long enough to know. And most people spending heavily on NAD haven’t first checked whether the symptoms they’re chasing are actually a hormonal or metabolic issue that NAD won’t fix.
If you want NAD evaluated as part of a broader optimization plan rather than as a standalone purchase, that’s exactly what Action TRT is built for, full hormonal and metabolic workup first, then matching therapies to what the labs and symptoms actually show.
